About William Steinkrauss
William Steinkrauss is an executive officer at Iliad Biotechnologies.
Form D filings also name William Steinkrauss as an executive officer at OcuTerra Therapeutics.
William Steinkrauss first appears on SEC filings in 2023.
Experience
This experience comes from William Steinkrauss's profile and from SEC filings. For roles taken from filings, the years are when the filings name William Steinkrauss in the role, so the role may have started earlier or lasted longer.
Iliad Biotechnologies, Inc. Current
Chief Operating Officer & Chief Financial Officer
2024 – Present · Weston, FL
Develops an investigational whooping cough vaccine for people at risk of infection.
OC
OWL CFO Consulting Current
President
2022 – Present
CS
COMPASS, Community Providers of Adolescent Services Current
Board Member
2020 – Present
PH
PureTech Health
Interim Chief Financial Officer
2022 – 2025
CU
Curis
Chief Financial Officer & Chief Administrative Officer
2016 – 2022
OV
OvaScience
Director Finance
2015 – 2016
CP
Cubist Pharmaceuticals
Senior Manager, Technical Accounting
2012 – 2015
PW
PwC
Manager, Transaction Services
2007 – 2012
Key Colleagues at Startups
The people William Steinkrauss works with at each company, as listed on that company's latest Form D.
Iliad Biotechnologies, Inc. · Form D, Feb 20, 2026
OcuTerra Therapeutics, Inc. · Form D/A, Feb 22, 2024
KB
Kerrie Brady
Chief Executive Officer and director
DE
D. Edwards
Executive officer
RS
Robin Steele
Director
DT
David Tanzer
Executive officer
WK
William Koster
Director
BF
Bruce Failing
Director
BR
Barbara Ryan
Director
BS
Brenton Saunders
Director
RR
Robert Ruffolo
Director